UroGen Pharma Ltd. has granted inducement restricted stock units (RSUs) to 14 new employees, with up to 32,500 ordinary shares issuable upon vesting and settlement. The RSUs will vest equally over three years, with one-third of the shares vesting each year on the anniversary of the grant date, contingent on continued employment with the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Urogen Pharma Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9597478-en) on December 05, 2025, and is solely responsible for the information contained therein.